*Department of Pediatric Oncology, Catholic University, “A. Gemelli” Hospital, Rome
†Département d’Oncologie Pédiatrique
‡Département de Pathologie
§Département d’Imagerie Médicale
***INSERM U830, Institut Curie
∥INSERM UMR745 & Service de Biochimie et Génétique Moléculaire, Hôpital Beaujon
¶Institut Curie, Unite de Génétique somatique
**AP-HP Hopital Necker-Enfants Malades, Service de Pathologie
‡‡Department of Pediatric Oncology, Institut Gustave Roussy
¶¶Université Paris Descartes, AP-HP Hopital Necker-Enfants Malades, Service de Chirurgie infantile
##Université Paris Diderot, Sorbonne Paris Cité, and Service de Pathologie, AP-HP, Hopital Robert Debré
#Centre Léon Bérard, Service de Pathologie
††Service de neuroptahologie, Hospices Civils de Lyon, Lyon
§§Service d’hémato-oncologie pédiatrique, CHU Rennes, Rennes
∥∥Service d’hémato-oncologie pédiatrique, Université Saint-Etienne, Saint-Etienne, France
Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website, www.ajsp.com.
Conflicts of Interest and Source of Funding: Supported by grants from the Associations Infosarcomes and Abigael. INSERM U830 is labelized by the Ligue Contre le Cancer. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Correspondence: Franck Bourdeaut, MD, PhD, INSERM U830 & Département d’oncologie pédiatrique, Institut Curie, Paris, France 75248 CEDEX05 (e-mail: [email protected])
